|
Autek China Inc. (300595.SZ) DCF Valuation
CN | Healthcare | Medical - Instruments & Supplies | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Autek China Inc. (300595.SZ) Bundle
As an investor or analyst, this (300595SZ) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Autek China Inc., you can adjust forecasts and instantly observe the effects.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 646.9 | 870.7 | 1,295.0 | 1,525.3 | 1,737.2 | 1,837.5 | 1,943.5 | 2,055.7 | 2,174.4 | 2,300.0 |
| Revenue Growth, % | 0 | 34.59 | 48.74 | 17.78 | 13.89 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 |
| EBITDA | 351.0 | 444.7 | 780.4 | 913.1 | 965.7 | 1,032.8 | 1,092.5 | 1,155.6 | 1,222.3 | 1,292.8 |
| EBITDA, % | 54.26 | 51.08 | 60.26 | 59.86 | 55.59 | 56.21 | 56.21 | 56.21 | 56.21 | 56.21 |
| Depreciation | 16.9 | 35.9 | 89.5 | 111.4 | 108.5 | 100.0 | 105.7 | 111.9 | 118.3 | 125.1 |
| Depreciation, % | 2.62 | 4.12 | 6.91 | 7.31 | 6.25 | 5.44 | 5.44 | 5.44 | 5.44 | 5.44 |
| EBIT | 334.1 | 408.8 | 690.8 | 801.7 | 857.2 | 932.9 | 986.7 | 1,043.7 | 1,104.0 | 1,167.7 |
| EBIT, % | 51.65 | 46.95 | 53.35 | 52.56 | 49.35 | 50.77 | 50.77 | 50.77 | 50.77 | 50.77 |
| Total Cash | 461.5 | 1,306.2 | 1,354.5 | 2,292.4 | 3,174.0 | 1,732.1 | 1,832.1 | 1,937.9 | 2,049.8 | 2,168.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 100.6 | 143.9 | 156.7 | 210.9 | 241.7 | 264.3 | 279.5 | 295.7 | 312.7 | 330.8 |
| Account Receivables, % | 15.55 | 16.53 | 12.1 | 13.82 | 13.91 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 |
| Inventories | 53.5 | 72.4 | 106.0 | 123.6 | 160.0 | 154.7 | 163.6 | 173.0 | 183.0 | 193.6 |
| Inventories, % | 8.27 | 8.31 | 8.18 | 8.11 | 9.21 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
| Accounts Payable | 24.9 | 44.2 | 37.4 | 49.0 | 72.0 | 70.4 | 74.5 | 78.8 | 83.3 | 88.2 |
| Accounts Payable, % | 3.84 | 5.08 | 2.89 | 3.21 | 4.14 | 3.83 | 3.83 | 3.83 | 3.83 | 3.83 |
| Capital Expenditure | -57.1 | -94.4 | -137.8 | -129.4 | -197.9 | -184.4 | -195.1 | -206.4 | -218.3 | -230.9 |
| Capital Expenditure, % | -8.83 | -10.84 | -10.64 | -8.48 | -11.39 | -10.04 | -10.04 | -10.04 | -10.04 | -10.04 |
| Tax Rate, % | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 | 21.31 |
| EBITAT | 307.1 | 383.4 | 560.4 | 628.7 | 674.6 | 791.0 | 836.6 | 884.9 | 936.0 | 990.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 137.7 | 282.0 | 458.9 | 550.5 | 540.9 | 687.7 | 727.1 | 769.1 | 813.5 | 860.5 |
| WACC, % | 8.54 | 8.55 | 8.54 | 8.54 | 8.54 | 8.54 | 8.54 | 8.54 | 8.54 | 8.54 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,009.7 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 891 | |||||||||
| Terminal Value | 17,671 | |||||||||
| Present Terminal Value | 11,730 | |||||||||
| Enterprise Value | 14,740 | |||||||||
| Net Debt | -712 | |||||||||
| Equity Value | 15,452 | |||||||||
| Diluted Shares Outstanding, MM | 893 | |||||||||
| Equity Value Per Share | 17.30 |
What You Will Receive
- Authentic 300595SZ Financial Data: Access to both historical and projected figures for precise valuation.
- Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and capital expenditures.
- Real-Time Calculations: Intrinsic value and NPV are calculated automatically and updated live.
- Scenario Planning: Evaluate various scenarios to project the future performance of Autek China Inc.
- User-Friendly Design: Designed for professionals while remaining easy to navigate for newcomers.
Key Features
- Comprehensive Data: Access Autek China Inc.'s historical financial statements along with pre-populated projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins to suit your needs.
- Real-Time Calculations: Watch Autek China Inc.'s intrinsic value update instantly as you adjust inputs.
- Visual Performance Metrics: Intuitive dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine Autek China Inc.'s (300595SZ) pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the results and leverage the findings for your investment strategies.
Why Opt for This Calculator?
- Reliable Data: Up-to-date financial information from Autek China Inc. ensures accurate valuation outcomes.
- Customizable Features: Tailor key metrics such as growth rates, WACC, and tax rates to fit your forecasts.
- Efficient: Pre-configured calculations save you the hassle of starting from scratch.
- Professional Quality: Crafted for investors, analysts, and consultants looking to enhance their evaluations.
- User-Friendly Design: A straightforward interface and clear guidance make it accessible for all users.
Who Can Benefit from Autek China Inc. (300595SZ)?
- Investors: Assess Autek's valuation to make informed decisions on buying or selling stocks.
- CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial projections.
- Startup Founders: Gain insights into how prominent public companies like Autek are appraised.
- Consultants: Provide clients with expert valuation assessments and reports.
- Students and Educators: Utilize real market data for hands-on practice and instruction in valuation strategies.
Contents of the Template
- Pre-Filled DCF Model: Autek China Inc.’s financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Autek China Inc.’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and CAPEX to align with your scenarios.
- Financial Statements: Annual and quarterly reports to facilitate in-depth evaluation.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.